Effect of Rauwolfa serpentina and Reserpine on the Blood Pressure in Essential Hypertension
- 1 August 1957
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 16 (2), 200-206
- https://doi.org/10.1161/01.cir.16.2.200
Abstract
A 2-year double-blind study of 18 ambulatory patients treated with Rauwolfia serpentina and reserpine is presented, with a statistical evaluation by the method of analysis of variance.Keywords
This publication has 19 references indexed in Scilit:
- RESERPINE-HYDRALAZINE COMBINATION THERAPY OF HYPERTENSIVE DISEASE, WITH HYDRALAZINE IN DOSES GENERALLY BELOW THE "TOXIC RANGE"Annals of Internal Medicine, 1956
- THE RAUWOLFIA ALKALOIDS IN THE TREATMENT OF HYPERTENSIONHeart, 1955
- How to evaluate a new drugThe American Journal of Medicine, 1954
- Effects of Placebo Administration and Occurrence of Toxic ReactionsJAMA, 1954
- CLINICAL EXPERIENCE WITH RESERPINE (SERPASIL): A CONTROLLED STUDYAnnals of the New York Academy of Sciences, 1954
- CLINICAL AND EXPERIMENTAL EFFECTS OF RESERPINE IN PATIENTS WITH ESSENTIAL HYPERTENSIONAnnals of the New York Academy of Sciences, 1954
- CLINICAL USAGE OF RAUWOLFIA ALKALOIDS, INCLUDING RESERPINE (SERPASIL)Annals of the New York Academy of Sciences, 1954
- NEW DRUG THERAPIES IN ARTERIAL HYPERTENSIONAnnals of Internal Medicine, 1952
- EFFECTS OF SUGGESTION AND CONDITIONING ON THE ACTION OF CHEMICAL AGENTS IN HUMAN SUBJECTS—THE PHARMACOLOGY OF PLACEBOS 12Journal of Clinical Investigation, 1950
- A CLINICAL TRIAL OF RAUWOLFIA SERPENTINA IN ESSENTIAL HYPERTENSIONHeart, 1949